Search

Filters
Clear All
  • 12
  • 46
  • 549

Phase

  • 9
  • 15
  • 55
  • 8
  • 69
  • 3
  • 442
  • 533
  • 259
  • 604
  • 3

Found 607 iu-health-enterprise-system trials

A listing of iu-health-enterprise-system medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
T
Tina Zhang
12 years - 20 years
All genders
Interventional
This study investigates the effects of fiber and anthocyanin complexes on microbial imbalance, known as dysbiosis, in children with ulcerative colitis (UC). Ulcerative colitis is a condition where inflammation causes sores in the digestive tract, affecting the colon. The purpose is to find combinations that support beneficial gut microbes, enhance …
M
Marc Rovner
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on people with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. The purpose of this study is to see how well the investigational medication works compared to a …
W
Weiming Mao
18 years - 100 years
All genders
Observational
What is the purpose of this study?Long anterior zonules (LAZ) is the presence of the zonular fibers (a tissue that holds the lens in place) attaching to the anterior part of the lens. LAZ is a rare disease and is genetically associated with certain gene mutations.  It has been reported …
M
Mohammad Al-Haddad, MD
18 years - 100 years
All genders
Observational
This study investigates the use of an investigational assay called PanCystPro to help doctors make decisions about treating pancreatic cysts. Pancreatic cysts are fluid-filled sacs on the pancreas, and some can lead to cancer. The PanCystPro test measures certain substances in the cyst fluid to determine if the cyst is …
R
Ryan Boente
40 years - 100 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on people with idiopathic pulmonary fibrosis (IPF). IPF is a lung disease that causes scarring and makes it hard to breathe. The purpose of this study is to learn about the safety and how well the investigational medication works compared to …
J
Jason Santiago
18 years - 100 years
All genders
Observational
This study investigates sleep disturbances, behavior, and daily activities in patients with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) who are starting treatment with an investigational medication. Dravet Syndrome and Lennox-Gastaut Syndrome are conditions that affect the brain and can cause seizures. This study looks at how the treatment affects …
S
Sandeep Batra, MD
366 days - 42 years
All genders
Phase 3
This study investigates treatments for a type of blood cancer called Philadelphia chromosome-positive or ABL-class Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (B-ALL). B-ALL is a cancer of the white blood cells. The study looks at the effects of combining blinatumomab, a special antibody that helps the immune system fight cancer, …
A
Anna Elizabeth Thomas
23 weeks - 27 weeks
All genders
Phase 2
Interventional
This study investigates bronchopulmonary dysplasia in extremely premature infants. Bronchopulmonary dysplasia is a serious lung condition that affects infants, particularly those born prematurely, causing breathing problems. The purpose of this study is to determine if an investigational medication can prevent this condition when compared to standard neonatal care.Participants in the …
M
Myda Khalid
2 years - 17 years
All genders
Interventional
This study investigates how an investigational medication affects children and teenagers with chronic kidney disease (CKD). Chronic kidney disease is a condition where the kidneys are damaged and cannot filter blood as well as they should. The purpose of this study is to see if the investigational medication is safe …
S
Sandeep Batra, MD
1 year - 30 years
All genders
Phase 2
Interventional
This study investigates the effects of two investigational medications, blinatumomab and nivolumab, in patients with B-cell acute lymphoblastic leukemia (B-ALL) that has relapsed. B-ALL is a type of cancer that affects the white blood cells. The study includes patients with Down syndrome and aims to compare the outcomes of using …
401 - 410 of 607